References
- Sachdeva A, Gunasekaran V, Ramya HN, et al. Consensus statement of the Indian Academy of Pediatrics in diagnosis and management of hemophilia. Indian Pediatr 2018; 55: 582–90.
- Gupta H, Dutta UP, Sengupta PP. The socioeconomic dimensions for the management of haemophilia in India: an empirical study. J Health Manag 2018; 20(1): 38–45. doi: 10.1177/097206341774699.
- Dutta A, Dutta TS, Kar S, Kakati S, Dowerah P. Study on clinical presentation of factor deficient patients presenting to a tertiary care centre of North East India. Journal of Medical Science and Clinical Research 2016; 4(7): 11533–38. doi: 10.18535/jmscr/v4i7.57.
- Dutta A, Dutta TS, Dey P. Clinical profile of haemophilia patients of Upper Assam – a hospital-based study. J Evol Med Dent Sci 2017;6(37):2990–93. doi: 10.14260/Jemds/2017/645.
- Rodriguez-Merchan EC. Local fibrin glue and chitosan-based dressings in haemophilia surgery. Blood Coagul Fibrinolysis 2012; 23(6): 473–6. doi: 10.1097/MBC.0b013e3283555379.
- Misgav M, Kenet G, Martinowitz U. Chitosan-based dressing for the treatment of external/accessible bleedings in children with bleeding tendency. J Pediatr Hematol Oncol 2014;36(2):140–2. doi: 10.1097/MPH.0b013e31828ac8b6.
- Dutta A, Das AK. Haemostasis action of VELSEAL-T in a haemophilia A patient with external bleeding. J Haem Pract 2018; 5(1): 4–7. doi: 10.17225/jhp00105.
- Forrest RD. Early history of wound treatment. J R Soc Med 1982; 75: 198–205.
- Lawrence JC. What materials for dressings? Injury 1982; 13: 500–12. doi: 10.1016/0020-1383(82)90166-8.
- Piskozub ZT. The efficiency of wound dressing materials as a barrier to secondary bacterial contamination. Br J Plast Surg 1968; 21(4): 387–401. doi: 10.1016/s0007-1226(68)80069-4.
- Thomas S, Dawes C, Hay NP. Wound dressing materials—testing and control. Pharm J 1982; 228: 576–8.
- Seaman S. Dressing selection in chronic wound management. J Am Podiatr Med Assoc 2002; 92(1): 24–33. doi: 10.7547/87507315-92-1-24.
- Sood A, Granick MS, Tomaselli NL. Wound dressings and comparative effectiveness data. Adv Wound Care (New Rochelle) 2014; 3(8): 511–29. doi: 10.1089/wound.2012.0401.
- Robinson BJ. The use of a hydrofibre dressing in wound management. J Wound Care 2000; 9(1): 32–4. doi: 10.12968/jowc.2000.9.1.25941.
- Thorn RM, Austin AJ, Greenman J, Wilkins JP, Davis PJ. In vitro comparison of antimicrobial activity of iodine and silver dressings against biofilms. J Wound Care 2009; 18(8): 343–6. doi: 10.12968/jowc.2009.18.8.43635.
- Spangler D, Rothenburger S, Nguyen K, et al. In vitro antimicrobial activity of oxidized regenerated cellulose against antibiotic resistant microorganisms. Surg Infect (Larchmt) 2003; 4(3): 255–62. doi: 10.1089/109629603322419599.
- Hofman D, Wilson J, Poore S, Cherry G, Ryan T. Can Traumacel be used in the treatment of chronic wounds? J Wound Care 2000; 9(8): 393–6. doi: 10.12968/jowc.2000.9.8.26280.
- Seyednejad H, Imani M, Jamieson T, Seifalian AM. Topical haemostatic agents. Br J Surg 2008; 95(10): 1197–225. doi: 10.1002/bjs.6357.
- Hino M, Ishiko O, Honda KI, et al. Transmission of symptomatic parvovirus B19 infection by fibrin sealant used during surgery. Br J Haematol 2000; 108(1): 194–5. doi: 10.1046/j.1365-2141.2000.01818.x.
- Pope M, Johnston KW. Anaphylaxis after thrombin injection of a femoral pseudoaneurysm: recommendations for prevention. J Vasc Surg 2000; 32(1): 190–1. doi: 101067/mva.2000.106498.
- Tadokoro K, Ohtoshi T, Takafuji S, et al. Topical thrombin-induced IgE-mediated anaphylaxis: RAST analysis and skin test studies. J Allergy Clin Immunol 1991; 88(4): 620–9. doi: 10.1016/0091-6749(91)90156-i.
- Wai Y, Tsui V, Peng Z, Richardson R, Oreopoulos D, Tarlo SM. Anaphylaxis from topical bovine thrombin (Thrombostat) during haemodialysis and evaluation of sensitization among a dialysis population. Clin Exp Allerg 2003; 33(12): 1730–4. doi: 10.1111/j.1365-2222-2003.01806.x.
- Schuhmacher C, Pratschke J, Weiss S, et al. Safety and effectiveness of a synthetic hemostatic patch for intraoperative soft tissue bleeding. Med Devices (Auckl) 2015; 8: 167–74. doi: 10.2147/MDER.S79556.
- Glineur D, Hendrikx M, Krievins D, et al. A randomized, controlled trial of Veriset™ hemostatic patch in halting cardiovascular bleeding. Med Devices (Auckl) 2018; 11: 65–75. doi: 10.2147/MDER.S145651.
- Kranokpiraksa P, Pavcnik D, Kakizawa H, et al. Hemostatic efficacy of chitosan-based bandage for closure of percutaneous arterial access sites: An experimental study in heparinised sheep model. Radiol Oncol 2010; 44(2): 86–91. doi: 10.2478/v10019-010-0021-0.
- Binet Q, Lambert C, Sacré L, Eeckhoudt S, Hermans C. Successful management of acquired hemophilia A associated with bullous pemphigoid: a case report and review of the literature. Case Rep Hematol 2017; 2017: 2057019. doi: 10.1155/2017/2057019.